Clinical Trials List
2017-03-23 - 2019-03-31
Phase II
Terminated3
ICD-10C25
Malignant neoplasm of pancreas
ICD-9157.3
Malignant neoplasm of pancreatic duct
-
-
Trial Applicant
ELI LILLY AND COMPANY(TAIWAN), INC.
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/15
Investigators and Locations
Co-Principal Investigator
- Yee Chao Division of Hematology & Oncology
- Yi-Ping Hung Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
9 Terminated
Audit
CRO
Co-Principal Investigator
- 趙盈瑞 Division of General Surgery
- 姜乃榕 Division of Hematology & Oncology
- Nai-Jung Chiang Division of Hematology & Oncology
- Li-Tzong Chen Division of Hematology & Oncology
- 劉奕廷 Division of Hematology & Oncology
- Chia-Jui Yen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Audit
None
Co-Principal Investigator
- Chih-Hung Hsu Division of Hematology & Oncology
- 呂理駿 Division of Hematology & Oncology
- 梁逸歆 Division of Hematology & Oncology
- Ann-Lii Cheng Division of Hematology & Oncology
- SHIH-HUNG YANG Division of Hematology & Oncology
- Hsiang-Fong Kao Division of Hematology & Oncology
- SHIH-HUNG YANG Division of Hematology & Oncology
- 林育麟 Division of Hematology & Oncology
- Wei-Wu Chen Division of Hematology & Oncology
- - - Division of General Internal Medicine
- Chiun Hsu Division of Hematology & Oncology
- JHE-CYUAN GUO Division of Hematology & Oncology
- 陳國興 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Study Contacts
- -
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
25 participants
-
Global
250 participants
